Sera Prognostics secures $36m to advance commercialisation of PreTRM test
Image: Sera Prognostics has secured funds to advance the commercialisation of PreTRM test. Photo: courtesy of Belova59 from Pixabay.
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X